Evidence map›Paper›PMID 31068441›Full record

ArticleScience translational medicine2019

TGF-β type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis.

Tieshi Li, Susan Chubinskaya, Alessandra Esposito, Xin Jin, Lidia Tagliafierro, Richard Loeser, Arnavaz A Hakimiyan, Lara Longobardi, Huseyin Ozkan, Anna Spagnoli

Open access · greenAbstract read
In one paragraph

Article in Science translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. A bioactive supramolecular and covalent polymer scaffold for cartilage repair in a sheep model.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Role of Interleukin-36 in inflammatory joint diseases.Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Review
  18. Article
  19. TGFβ1Nature communications · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Tieshi LiDepartment of Pediatrics, Rush University Medical Center, Chicago, IL 60612, USA.ORCID 0000-0002-7656-1854
Susan ChubinskayaDepartment of Pediatrics, Rush University Medical Center, Chicago, IL 60612, USA.
Alessandra EspositoDepartment of Pediatrics, Rush University Medical Center, Chicago, IL 60612, USA.ORCID 0000-0003-0664-3122
Xin JinDepartment of Pediatrics, Rush University Medical Center, Chicago, IL 60612, USA.
Lidia TagliafierroDepartment of Neuroscience, Duke University, Durham, NC 27708, USA.
Richard LoeserDepartment of Medicine, Division of Rheumatology, Allergy, and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0003-2832-6144
Arnavaz A HakimiyanDepartment of Pediatrics, Rush University Medical Center, Chicago, IL 60612, USA.ORCID 0000-0002-2571-4128
Lara LongobardiDepartment of Medicine, Division of Rheumatology, Allergy, and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Huseyin OzkanDepartment of Medicine, Division of Rheumatology, Allergy, and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Anna SpagnoliDepartment of Pediatrics, Rush University Medical Center, Chicago, IL 60612, USA. anna.spagnoli@unmc.edu.ORCID 0000-0002-4497-7150
Rush University Medical Center · USUniversity of North Carolina at Chapel Hill · USDuke University · US

Funding

Oxidative Stress and the Development of OsteoarthritisR01AG044034 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RICHARD F LOESER · 2012 to 2026
$5.7M
Integrin Function in CartilageR37AR049003 · NIAMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LOESER, RICHARD F · 2012 to 2021
$4.1M
Molecular Mechanisms in Joint DevelopmentR01AR057042 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SPAGNOLI, ANNA · 2010 to 2014
$1.6M
NIAMS NIH HHS R01 AR057042NIAMS NIH HHS R37 AR049003NIA NIH HHS R01 AG044034
6 · The paper itself

Abstract

Mechanisms that govern the shift from joint homeostasis to osteoarthritis (OA) remain unknown. Here, we identify a pathway used for joint development and homeostasis, and its role in OA. Using a combination of transgenic, pharmacological, and surgical conditions in mouse and human tissues, we found that TGF-β signaling promotes joint homeostasis through regulation of the IL-36 family. We identified IL-36 receptor antagonist (IL-36 in mice and IL-36RN in humans) as a potential disease-modifying OA drug. Specifically, OA development was associated with IL-36α up-regulation and IL-36Ra down-regulation in mice with tissue-specific postnatally induced ablation of

Indexed as

Molecular Targeted TherapyAgingAnimalsChondrocytesDisease ProgressionDown-RegulationHumansInjections, Intra-ArticularInterleukin-1JointsMatrix Metalloproteinase 13MiceMice, KnockoutOsteoarthritisPhenotypeReceptors, Interleukin-1Il1rl2 protein, mouseInterleukin-1interleukin 1F6, mouseinterleukin 36, humanMatrix Metalloproteinase 13MMP13 protein, humanReceptors, Interleukin-1Receptor, Transforming Growth Factor-beta Type II

Identifiers

PMID31068441
PMCPMC7102613
OpenAlexW2944137118

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.